THY1 and ocular melanoma: The immunophenotype of OM-MSCs identified by flow cytometry exhibited positive expression of MSC markers (CD44, CD73, CD90, CD105, CD133, and CD146) and negative expression of hematopoietic stem cell (HSC) markers (CD34 and CD45; Figure 1B).